Document is current
Any future updates will be listed below
-
Authors
Schommers, Philipp https://orcid.org/0000-0003-3375-6800
Kim, Dae Sung https://orcid.org/0000-0002-3191-437X
Schlotz, Maike
Kreer, Christoph https://orcid.org/0000-0002-9140-9850
Eggeling, Ralf https://orcid.org/0000-0002-3583-1029
Hake, Anna
Stecher, Melanie
Park, Juyeon
Radford, Caelan E.
Dingens, Adam S.
Ercanoglu, Meryem S.
Gruell, Henning https://orcid.org/0000-0002-0725-7138
Odidika, Stanley
Dahlhaus, Marten
Gieselmann, Lutz
Ahmadov, Elvin
Lawong, Rene Y.
Heger, Eva
Knops, Elena https://orcid.org/0000-0001-7398-3026
Wyen, Christoph
Kümmerle, Tim
Römer, Katja
Scholten, Stefan
Wolf, Timo https://orcid.org/0000-0002-3819-9540
Stephan, Christoph https://orcid.org/0000-0003-3777-9006
Suárez, Isabelle
Raju, Nagarajan
Adhikari, Anurag https://orcid.org/0000-0003-3168-0558
Esser, Stefan
Streeck, Hendrik
Duerr, Ralf https://orcid.org/0000-0001-9569-9237
Nanfack, Aubin J.
Zolla-Pazner, Susan https://orcid.org/0000-0002-0750-2666
Geldmacher, Christof
Geisenberger, Otto
Kroidl, Arne https://orcid.org/0000-0003-3569-9176
William, Wiston
Maganga, Lucas
Ntinginya, Nyanda Elias
Georgiev, Ivelin S.
Vehreschild, Jörg J.
Hoelscher, Michael https://orcid.org/0000-0002-7642-1835
Fätkenheuer, Gerd
Lavinder, Jason J.
Bloom, Jesse D. https://orcid.org/0000-0003-1267-3408
Seaman, Michael S.
Lehmann, Clara https://orcid.org/0000-0002-7042-1578
Pfeifer, Nico
Georgiou, George https://orcid.org/0000-0002-8823-3073
Klein, Florian https://orcid.org/0000-0003-1376-1792
- License Information
-
More Information
Article History
Received: 26 February 2023
Accepted: 7 September 2023
First Online: 13 November 2023
Competing interests
: A patent application encompassing aspects of this work has been filed by the University of Cologne and lists P.S., H.G. and F.K. as inventors. P.S., H.G. and F.K. received payments from the University of Cologne for licensed antibodies. J.D.B. is on the scientific advisory boards of Apriori Bio, Invivyd, Aerium Therapeutics and the Vaccine Company. J.D.B., C.E.R. and A.S.D. receive royalty payments as inventors on Fred Hutch licensed patents related to viral DMS. A.S.D. is currently an employee of Apriori Bio, although his contributions to this manuscript were performed when he was an employee of Fred Hutch before he started work at Apriori Bio. The remaining authors declare no competing interests.
